Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shock wave or nerve block: which eases Post-Stroke shoulder pain better?

NCT ID NCT07485192

Symptom relief Sponsor: Kars State Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two treatments for shoulder pain in people who had a stroke. 67 patients received either standard care, a nerve block injection, or shock wave therapy. The goal was to see which approach reduced pain and improved movement over 3 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

67 people

The number who actually took part.

Started

Apr 2023

Finished

Jan 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients diagnosed with hemorrhagic or ischemic stroke at least 3 months prior to enrollment. Patients with shoulder pain of at least 5 cm on the 10-cm Visual Analog Scale (VAS) following hemiplegia. Patients aged 45-70 years. Patients with partial tear of the supraspinatus muscle/tendon confirmed by ultrasonographic evaluation. Exclusion Criteria: * Patients with limited cooperation. Patients who received local anesthetic or corticosteroid injection to the shoulder region within the last 3 months. Patients with a history of surgery or radiotherapy in the shoulder region. Patients with pre-existing shoulder pain prior to the diagnosis of stroke. Patients with a cardiac pacemaker. Patients with malignancy or signs of acute inflammation in the treatment area. Patients with coagulation disorders or an INR ≥ 4. Patients with vascular conditions such as deep vein thrombosis, phlebitis, varicose veins, or arterial disease.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiplegic shoulder pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemiplegic shoulder pain

Contacts and locations

Locations

  • Başakşehir Çam and Sakura City Hospital

    Istanbul, Başakşehir, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.